  |
 |
 |
 |
 |
 |
 |
 |
 |
|
|||||||||||||||
|
|||||||||||||||
 |
 |
|
|
|
science & public policy
[ public policy ] [ science ] [ personalized medicine 101 ] [ related articles & presentations ] [ pmc task forces ] public policy issues impacting personalized medicine overview • health information technology • intellectual property • regulatory oversight • research funding and support • public and private sector reimbursement • privacy, confidentiality and patients' rights • payer principles • CLIA and genetic testing • comparative effectiveness • incentives for personalized medicine • A strong intellectual property system is necessary to stimulate investment in innovation. It is essential that government patent systems offer protection for innovations relating to personalized medicine, as well as high quality patent examination that allows patents of appropriate scope and quality. |
|
|
|
|
|
|
 |
|
 |
|
 |
